查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378873

神经退化性疾病治疗市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Neurodegenerative Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球神经退化性疾病治疗市场规模达709亿美元。展望未来， IMARC Group预计到2028年市场规模将达到972亿美元，2022-2028年复合年增长率（CAGR）为5.4%。

神经退化性疾病是指导致中枢神经系统（CNS）或週边神经系统（PNS）神经元结构和功能进行性退化的一组脑部疾病。目前，有几种药物可以减轻身体或精神症状并改善患者的生活品质。此外，研究人员正致力于开发分子诊断技术，特别是生物标记和成像光谱学，以在早期阶段检测和诊断神经退化性疾病并预防其进展。

由于过量饮酒而导致的肿瘤和中风盛行率不断上升，加上老年人口不断增加，这是增加神经退化性疾病风险的主要因素之一。这进一步增加了对分子诊断技术的需求，以早期诊断神经退化性疾病，包括阿兹海默症、帕金森氏症、亨丁顿舞蹈症和肌萎缩性侧索硬化症。除此之外，研究人员正在将神经病理学方法与分子生物学技术结合，以有效地了解这些疾病的分类。他们也正在开发针对不同类型神经退化性疾病的微创（MI）筛检测试。此外，许多国家的管理机构以及非政府组织 (NGO) 正在支持各种健康教育活动，以提高人们对神经退化性疾病风险因素的认识。其他因素，例如由于基础设施改善和可支配收入增加而增加使用医疗保健设施的机会，预计将在未来几年推动市场的成长。

本报告回答的关键问题：

  • 迄今为止，全球神经退化性疾病治疗市场表现如何，未来几年将如何表现？
  • COVID-19 对全球神经退化性疾病治疗市场有何影响？
  • 主要区域市场有哪些？
  • 根据指示，市场的细分是什么？
  • 根据药物类型分類的市场是怎么样的？
  • 根据给药途径，市场的分化为何？
  • 基于配销通路的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球神经退化性疾病治疗市场的结构如何？谁是关键参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球神经退化性疾病治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按迹象分類的市场

  • 多发性硬化症
    • 市场走向
    • 市场预测
  • 帕金森氏症
    • 市场走向
    • 市场预测
  • 阿兹海默氏症
    • 市场走向
    • 市场预测
  • 脊髓性肌肉萎缩症 (SMA)
    • 市场走向
    • 市场预测
  • 亨丁顿舞蹈症
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按药物类型分類的市场细分

  • N-甲基-D-天门冬胺酸受体拮抗剂
    • 市场走向
    • 市场预测
  • 选择性血清素再摄取抑制剂
    • 市场走向
    • 市场预测
  • 多巴胺抑制剂
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按管理途径分類的市场

  • 口服
    • 市场走向
    • 市场预测
  • 可注射
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按配销通路分類的市场区隔

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Biogen
    • Boehringer Ingelheim International GmbH
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline Plc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
    • UCB SA
Product Code: SR112023A3102

Abstract

The global neurodegenerative disease treatment market size reached US$ 70.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 97.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2022-2028.

Neurodegenerative diseases refer to a group of brain disorders that lead to progressive degeneration of the structure and function of neurons in the central nervous system (CNS) or peripheral nervous system (PNS). Presently, several medications are available to reduce physical or mental symptoms and improve the quality of patients' life. Moreover, researchers are focusing on developing molecular diagnostics, especially biomarkers and imaging spectroscopy, to detect and diagnose neurodegenerative diseases at an early stage and prevent their progression.

The growing prevalence of tumors and stroke on account of excessive alcohol consumption, in confluence with the rising geriatric population, represents one of the major factors increasing the risk of developing neurodegenerative diseases. This is further escalating the need for molecular diagnostic techniques for early diagnosis of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. Apart from this, researchers are combining neuropathological methods with molecular biology techniques to understand the classification of these diseases effectively. They are also developing minimally invasive (MI) screening tests for different types of neurodegenerative diseases. Furthermore, governing agencies of numerous countries, along with non-governmental organizations (NGOs), are supporting various health education campaigns to generate awareness about the risk factors of neurodegenerative diseases. Other factors, such as increasing access to healthcare facilities on account of improving infrastructure and inflating disposable incomes, are anticipated to drive the growth of the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neurodegenerative disease treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on indication, drug type, route of administration and distribution channel.

Breakup by Indication:

Multiple Sclerosis

Parkinson's Disease

Alzheimer's Disease

Spinal Muscular Atrophy (SMA)

Huntington's Disease

Others

Breakup by Drug Type:

N-methyl-D-aspartate Receptor Antagonists

Selective Serotonin Reuptake Inhibitors

Dopamine Inhibitors

Others

Breakup by Route of Administration:

Oral

Injectable

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biogen, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd. and UCB S.A.

Key Questions Answered in This Report:

  • How has the global neurodegenerative disease treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global neurodegenerative disease treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neurodegenerative disease treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurodegenerative Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Indication

  • 6.1 Multiple Sclerosis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Parkinson's Disease
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Alzheimer's Disease
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Spinal Muscular Atrophy (SMA)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Huntington's Disease
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 N-methyl-D-aspartate Receptor Antagonists
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Selective Serotonin Reuptake Inhibitors
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dopamine Inhibitors
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Injectable
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Biogen
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Boehringer Ingelheim International GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 F. Hoffmann-La Roche AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 GlaxoSmithKline Plc
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 Merck & Co. Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Novartis AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Sanofi S.A
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Teva Pharmaceutical Industries Ltd.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 UCB S.A
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Neurodegenerative Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Neurodegenerative Disease Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Neurodegenerative Disease Treatment Market: Breakup by Indication (in %), 2022
  • Figure 5: Global: Neurodegenerative Disease Treatment Market: Breakup by Drug Type (in %), 2022
  • Figure 6: Global: Neurodegenerative Disease Treatment Market: Breakup by Route of Administration (in %), 2022
  • Figure 7: Global: Neurodegenerative Disease Treatment Market: Breakup by Distribution Channel (in %), 2022
  • Figure 8: Global: Neurodegenerative Disease Treatment Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Neurodegenerative Disease Treatment (Parkinson's Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Neurodegenerative Disease Treatment (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Neurodegenerative Disease Treatment (Alzheimer's Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Neurodegenerative Disease Treatment (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Neurodegenerative Disease Treatment (Huntington's Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Neurodegenerative Disease Treatment (Huntington's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Neurodegenerative Disease Treatment (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Neurodegenerative Disease Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Neurodegenerative Disease Treatment (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Neurodegenerative Disease Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia-Pacific: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia-Pacific: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Middle East and Africa: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2022
  • Figure 90: Global: Neurodegenerative Disease Treatment Industry: SWOT Analysis
  • Figure 91: Global: Neurodegenerative Disease Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Neurodegenerative Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurodegenerative Disease Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 3: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 4: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 5: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 6: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Neurodegenerative Disease Treatment Market: Competitive Structure
  • Table 8: Global: Neurodegenerative Disease Treatment Market: Key Players